The growing elderly population worldwide represents a major challenge for caregivers,
healthcare providers, and society. Older patients have a higher prevalence of cardiovascular …

The value of primary preventative therapies for cardiovascular disease (CVD) in older adults
(age≥ 75 years) is less certain than in younger patients. There is a lack of quality evidence …

Abstract Purpose of Review The utility of aspirin and statins for primary prevention of
atherosclerotic cardiovascular disease remains ambiguous in older adults. Current …

Aspirin and nonaspirin nonsteroidal anti-inflammatory drugs (naNSAIDs) are prescribed for
pain and fever relief. Evidence from clinical trials shows numerous pleiotropic effects that …

BACKGROUND: At present, the treatment for acute myocardial infarction has achieved great
progress. Reperfusion therapy in the short term can effectively reduce recurrence rates and …

В последние годы в мире наблюдается положительная тенденция в развитии
профилактической медицины, в частности, первичной профилактики заболеваний …

Background Recent cardiovascular guideline updates recommend against the use of aspirin
for primary prevention of atherosclerotic cardiovascular disease (ASCVD) in older people …

Abstract INTRODUÇÃO: As doenças do aparelho circulatório são a principal causa de morte
no Brasil e no mundo. O uso da aspirina na prevenção secundária de doenças …

In recent years there is a positive trend in the development of preventive medicine, in
particular, primary prevention of diseases. However, in most cases, patients seek help from …

The preliminary statements for the OPTI-3S criteria (n= 109) in Chapter 3 (Section 3.3. 3)
were split and reworded in accordance with the comments and feedback from the experts …